The European Respiratory Society (ERS) International Congress 2023

Acetazolamide helps patients with COPD reach new peaks

Elvira Manzano, 20231002000000

Acetazolamide helps to reduce the chances of altitude-related adverse health effects (ARAHE) in patients with chronic obstructive pulmonary disease (COPD) in a study reported at ERS.

Tacrolimus or cyclosporine for CLAD: The better of 2 immunosuppressants

Elvira Manzano, 20230928000000

Tacrolimus given once daily significantly reduced the 3-year incidence of chronic lung allograft dysfunction (CLAD) in lung transplant patients compared with standard immunosuppressant in the open label, multicentre, ScanCLAD trial presented at ERS 2023.

Dupilumab improves lung function in children with moderate-to-severe type 2 asthma

Elaine Soliven, 20230926000000

Treatment with dupilumab significantly improves lung function in children with moderate-to-severe type 2 asthma compared with placebo, according to two post hoc analyses presented at ERS 2023.

Is CPAP cardioprotective?

Audrey Abella, 20230925100000

Two studies presented at ERS 2023 demonstrated the potential of a continuous positive airway pressure (CPAP) machine to address cardiovascular (CV) risks in individuals with obstructive sleep apnoea (OSA).

Vaping tied to chronic stress, poor QoL in young adults

Stephen Padilla, 20230923120000

Use of e-cigarette (EC) shows a significant relation with a higher incidence of chronic stress and is indicative of poorer quality of life (QoL) in young adults, suggests a study presented at ERS 2023.

Fatigue in COPD influenced by multiple contributing factors

Jairia Dela Cruz, 20230922180000

Fatigue in people with chronic obstructive pulmonary disease (COPD) may be caused by factors such as shortness of breath, sleep quality, pain, and fatigue-related catastrophizing, according to the FAntasTIGUE study.

Benralizumab helps maintain severe asthma control with reduced ICS doses

Jairia Dela Cruz, 20230922140000

Treatment with benralizumab allows tapering of inhaled corticosteroid (ICS) doses for patients with severe eosinophilic asthma, without compromising disease control and increasing exacerbations, as shown in the results of the phase IV SHAMAL study.

Varenicline for smoking cessation in teens?

Smoking speeds up ageing process

Stephen Padilla, 20230922120000

A recent Mendelian randomization (MR) study provides genetic evidence showing that smoking can accelerate ageing as a result of shortened leucocyte telomere length (LTL). However, quitting may help reduce such risk.

Benralizumab reduces asthma exacerbations in Asians

Elaine Soliven, 20230922000000

Treatment with benralizumab significantly reduces the annual asthma exacerbation rate (AAER) among Asian patients with severe uncontrolled asthma compared with placebo, according to a subgroup analysis of the MIRACLE trial presented at ERS 2023.

One in eight adults experience long COVID

Chlorpheniramine nasal spray alleviates long COVID symptoms

Jairia Dela Cruz, 20230921140000

Inhaled chlorpheniramine maleate appears to reduce the risk of prolonged post-COVID symptoms, according to a study presented at ERS Congress 2023.